Leukopaks
A leukopak is a blood-derived product rich in mononuclear leukocytes (ie, lymphocytes and monocytes). Leukopaks are useful for researchers looking for a large number of leukocytes to cover large scale needs.
Our Leukopaks are obtained through leukapheresis following GMP procedures.
Leukopaks Features
Source: Leukopaks are collected at our licensed leukapheresis centers located in Germany.
Format: Fresh non-mobilized leukopaks.
Donors Criteria: Donors have an approved consent for donating leukocytes. All donors are screened to ensure that each of them is in good health condition and that products are not collected from a high-risk population for blood-borne infections.
Donor Data Provided: Age, gender and race.
Use: For Research use only (RUO) as a source of PBMCs.
Viral Testing: Each donor is tested for the standard German-required viral markers and found negative for HBsAg, anti-HBc, HIV-1/2-Ab, HCV-Ab, HIV-1-NAT, HCV-NAT, HBV-NAT, HAV-NAT, PVB19-NAT, HEV-NAT, WNV-NAT (tested from June to November) and syphilis.
Leukopaks Specifications
| Parameter | Specification | Parameter | Specification |
|---|---|---|---|
| Origin of leukopak | Europe (Germany) | Platelet concentration | 1600 to 5200 x109/L |
| Package volumen | 170 to 240 ml / Bag | Hemoglobin concentration | ≤ 0.5 mmol/L |
| Obtention method | Leukapheresis (Spectra Optia system) |
Hematocrit | ≤ 0.07 L/L |
| Leukocyte concentration | ≥ 40 x109 cells/L | Monocyte concentration | ≥ 5 x109 cells/L |
| Virus testing | "HBsAg, anti-HBc, HIV-1/2-Ab, HCV-Ab, HIV-1-NAT, HCV-NAT, HBV-NAT, HAV-NAT, PVB19-NAT, HEV-NAT WNV-NAT* and syphilis" | Lymphocyte concentration | ≥ 28 x109 cells/L |
*tested from 01.06 to 30.11
For more information on product availability or customization, please contact us here.
The information contained in these webpages are intended for a professional audience of pharmaceutical and in vitro diagnostic manufacturing personnel.